DUBAI, United Arab Emirates, Jan. 21, 2022 (GLOBE NEWSWIRE) -- U.S. Compounding Pharmacies Market is projected to exceed US$ 4.64 Bn In 2022 and is expected to grow at over 5.1% CAGR between 2022 and 2028. Increasing focus on introducing innovative formulations to combat several diseases is driving the growth in the market.
According to a recent research by Future Market Insights (FMI), the global compounding pharmacies market is estimated to have accounted around US$ 4.64 Bn in terms of value during 2022. The report on the U.S. Compounding Pharmacies Market also projects that the market will grow at a CAGR of approximately 5.1% during the period 2022-2028.
| Attribute | Details | |
| U.S. Compounding Pharmacies Market Estimated Size in 2022 | US$ 4.64 Bn | |
| U.S. Compounding Pharmacies Market Projected Size in 2028 | US$ 6.27 Bn | |
| U.S. Compounding Pharmacies Market Historical CAGR (2013-2021) | 5.8% | |
| U.S. Compounding Pharmacies Market Value-based CAGR (2022-2028) | 5.1% | |
Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-us-978
The U.S. compounding pharmacies market revenue is expected to increase at a robust growth rate over the next few years despite the reporting of several adverse events and drug mismanagement-related deaths. The U.S. compounding pharmacies market is expected to gain popularity in several regions of the U.S. due to upcoming products and therapeutic areas that are yet to be tapped by branded manufacturers.
Focus on factors, such as the availability of drugs in innovative medium/forms and the administration of varying dosages for various indications, is expected to drive the adoption of newer dosage forms of compounded medications.
Market Remains Influenced by Availability of Compounded Pain Management Drugs
The growing popularity of pain management therapies is fuelling the growth of U.S. compounding pharmacies market. Compounded pain management drugs are not FDA-approved, however, they come under the State Pharmacies Board supervision in the U.S.
For example, medical guidelines such as the Chronic Pain Guidelines stated by the Medical Treatment Utilization Schedule (MTUS) do not support the use of compounds such as Gabapentin and Baclofen for pain management. However, compounding pharmacies use these compounds as well as several others in varying strengths to attract customers and increase their revenue.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-us-978
Scope of the Report
| Attribute | Details |
| Forecast Period | 2022-2028 |
| Historical Data Available for | 2013-2021 |
| Market Analysis | US$ Bn for Value |
| Key Regions Covered | North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
| Key Market Segments Covered | Product, Pharmacy Type, Application, and Sterility |
| Key Companies Profiled | • Avella Specialty Pharmacy • Central Admixture Pharmacy Services Inc. • Hoye’s Pharmacy • Vertisis Custom Pharmacy • Smith Caldwell Drug Store • Sixth Avenue Medical Pharmacy • Cantrell Drug Company • Clinigen Group, Dougherty’s Pharmacy • Fagron N.V. |
Moreover, an increase in the shortage of prescription medicine is expected to upsurge the demand for compounding pharmacies. According to the U.S. FDA, only 154 drugs were in short supply or not available in 2007, as compared to 456 in 2012.
Currently, the number of drugs in short supply is around 300. Medicinal drought is prominent in the U.S. as compared to other countries, which is also fuelling the revenue growth of the U.S. compounding pharmacies market.
On the other hand, increasing regulatory pressures are expected to hamper the growth of the U.S. compounding pharmacies market. Compounding pharmacies are engaged in trans-boundary drug compounding, and the manufacturing of bulk drugs & ingredients need to be registered with the FDA, undergo mandatory inspections, and abide by GMP guidelines.
For instance, the FDA has stated that around 70% of registered firms have been inspected, of which 28 firms have been issued FDA Form 483s (non-adherence to cGMP regulations and unsafe compounding practices), and five warning letters, which implies a very high rate of action.
Compounding pharmacies registering with the FDA could serve to increase credibility. However, inspections and compliance with good manufacturing practices is compulsory. Regulatory pressures on compounding pharmacies are expected to force the smaller ones to close their business primarily due to unsafe compounding practices, which are likely to directly impact patient safety.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-us-978
Hormone Replacement Therapeutic Area to Hold over 38% Revenue Share in Market
By product type, oral medication is expected to dominate the U.S. compounding pharmacies market in terms of revenue, which is then followed by topical medication. The injectable segment by product type of the U.S. compounding pharmacies market is projected to grow at a significant rate as compared to other segments.
The hormone replacement therapy segment is the leading segment in terms of revenue among all the therapeutic area segments of the U.S. compounding pharmacies market, and is estimated to gain a 38.4% revenue share in 2022.
Among the pharmacy type segments, the 503A pharmacy segment is expected to gain a major revenue share as compared to the 503B pharmacy segment over the forecast period. By application, the adults segment is estimated to dominate the U.S. compounding pharmacies market, followed by the paediatrics segment. The veterinary segment is expected to grow at a faster pace as compared to the other application segments of the U.S. compounding pharmacies market.
Buy Now@ https://www.futuremarketinsights.com/checkout/978
The U.S. compounding pharmacies market report tracks some of the key companies operating in the market, which include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Inc., Fagron N.V., Wedgewood Pharma, PharMEDium Services LLC, Doughertys Pharmacy, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Village Compounding Pharmacy, Triangle Compounding Pharmacy, Olympia Pharmacy, Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, AIS HealthCare, Soleo Health, Millers Pharmacy, Centene Corporation, Infinity Care Solutions, Triumph Pharmacy, and Sixth Avenue Medical Pharmacy.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Pharma and Healthcare Social Media Market - Pharma and healthcare social media marketing is an area that is extremely relevant to the modern, digital age, where stakeholders in the pharmaceuticals and healthcare industries are reaching out to their potential customers through digital, social media platforms.
Pharmacy And Drug Store Franchises Market - A critical driver for the Pharmacy & Drug Store Franchises market is the widespread adoption of generic drugs. These drugs are identical to branded drugs in dosage, safety, strength, method of administration, characteristics & purpose of use.
Pharmaceuticals Excipients Market - Excipients can be classified into 7 categories on the basis of the kind of function they perform: diluents, binders, disintegrants, glidants, lubricants, tablet coating & films and coloring agents.
Infusion Pharmacy Management Market - Infusion therapy is type of medication through a needle or catheter. Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective.
Anti-Neoplastic Pharmaceutical Agents Market - Anti-neoplastic pharmaceutical agents are the drugs which prevent or inhibit the maturation and proliferation of neoplasms and thus helps in the management of cancer. These agents are also known as cytotoxic agents.
Topical Antibiotic Pharmaceuticals Market - Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections.
Pharmaceutical Solid Dosage Contract Manufacturing Market - The global Pharmaceutical contract manufacturing market currently is one of the rapidly growing market, and it is expected to show excellent opportunities in forecasted period.
Pharmerging Contract Manufacturing Market - Pharmerging markets indicate the most promising emerging markets in the pharmaceutical domain. Most of these markets are currently exhibiting growth rates moderate to high indicating sustainable demand prospects.
Pharmacy And Reagent Storage Refrigerators Market - Pharmacy and reagent storage refrigerators provide the reliability and security essential for the protection of sensitive lab samples. They are ideal for the demanding requirements of daily lab applications.
Biopharmaceutical Oral Drug Delivery Market - Biopharmaceuticals are the drugs produced by using biotechnology. Biopharmaceutical products are normally protein (antibodies), nucleic acids (DNA, RNA or oligonucleotides). They are used for therapeutic and in-vivo diagnostic purpose.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/us-compounding-pharmacies-market
Press Release Source: https://www.futuremarketinsights.com/press-release/us-compounding-pharmacies-market
